What is the intrinsic value of MD?
As of 2025-12-28, the Intrinsic Value of MEDNAX Inc (MD) is
9.44 USD. This MD valuation is based on the model Peter Lynch Fair Value.
With the current market price of 21.87 USD, the upside of MEDNAX Inc is
-56.82%.
Is MD undervalued or overvalued?
Based on its market price of 21.87 USD and our intrinsic valuation, MEDNAX Inc (MD) is overvalued by 56.82%.
MD Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
(64.38) - (15.73) |
(23.60) |
-207.9% |
| DCF (Growth 10y) |
(15.00) - (54.52) |
(21.44) |
-198.0% |
| DCF (EBITDA 5y) |
(10.37) - (11.12) |
(1,234.50) |
-123450.0% |
| DCF (EBITDA 10y) |
(11.30) - (12.54) |
(1,234.50) |
-123450.0% |
| Fair Value |
9.44 - 9.44 |
9.44 |
-56.82% |
| P/E |
38.79 - 61.19 |
47.45 |
117.0% |
| EV/EBITDA |
35.82 - 42.83 |
40.06 |
83.2% |
| EPV |
36.36 - 48.61 |
42.48 |
94.3% |
| DDM - Stable |
24.18 - 109.02 |
66.60 |
204.5% |
| DDM - Multi |
(12.04) - (41.90) |
(18.67) |
-185.3% |
MD Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
1,878.20 |
| Beta |
0.75 |
| Outstanding shares (mil) |
85.88 |
| Enterprise Value (mil) |
2,140.64 |
| Market risk premium |
4.60% |
| Cost of Equity |
7.51% |
| Cost of Debt |
6.20% |
| WACC |
6.84% |